Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 IBS-D Drugs
1.2.3 IBS-C Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Women
1.3.3 Men
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Perspective (2018-2034)
2.2 Rx Irritable Bowel Syndrome (IBS) Drugs Growth Trends by Region
2.2.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Size by Region (2018-2023)
2.2.3 Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Region (2024-2034)
2.3 Rx Irritable Bowel Syndrome (IBS) Drugs Market Dynamics
2.3.1 Rx Irritable Bowel Syndrome (IBS) Drugs Industry Trends
2.3.2 Rx Irritable Bowel Syndrome (IBS) Drugs Market Drivers
2.3.3 Rx Irritable Bowel Syndrome (IBS) Drugs Market Challenges
2.3.4 Rx Irritable Bowel Syndrome (IBS) Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Revenue
3.1.1 Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Revenue (2018-2023)
3.1.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue
3.4 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Concentration Ratio
3.4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in 2024
3.5 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players Head office and Area Served
3.6 Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Product Solution and Service
3.7 Date of Enter into Rx Irritable Bowel Syndrome (IBS) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rx Irritable Bowel Syndrome (IBS) Drugs Breakdown Data by Type
4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Size by Type (2018-2023)
4.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Type (2024-2034)
5 Rx Irritable Bowel Syndrome (IBS) Drugs Breakdown Data by Application
5.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Size by Application (2018-2023)
5.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2018-2034)
6.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2018-2023)
6.4 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2018-2034)
7.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2018-2023)
7.4 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2018-2034)
8.2 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2018-2034)
9.2 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2018-2023)
9.4 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2018-2034)
10.2 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ironwood Pharmaceuticals
11.1.1 Ironwood Pharmaceuticals Company Detail
11.1.2 Ironwood Pharmaceuticals Business Overview
11.1.3 Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
11.1.4 Ironwood Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2018-2023)
11.1.5 Ironwood Pharmaceuticals Recent Development
11.2 Bausch Health
11.2.1 Bausch Health Company Detail
11.2.2 Bausch Health Business Overview
11.2.3 Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
11.2.4 Bausch Health Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2018-2023)
11.2.5 Bausch Health Recent Development
11.3 Takeda
11.3.1 Takeda Company Detail
11.3.2 Takeda Business Overview
11.3.3 Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
11.3.4 Takeda Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2018-2023)
11.3.5 Takeda Recent Development
11.4 Sebela Pharmaceuticals
11.4.1 Sebela Pharmaceuticals Company Detail
11.4.2 Sebela Pharmaceuticals Business Overview
11.4.3 Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
11.4.4 Sebela Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2018-2023)
11.4.5 Sebela Pharmaceuticals Recent Development
11.5 Allergan
11.5.1 Allergan Company Detail
11.5.2 Allergan Business Overview
11.5.3 Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
11.5.4 Allergan Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2018-2023)
11.5.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of IBS-D Drugs
Table 3. Key Players of IBS-C Drugs
Table 4. Key Players of Others
Table 5. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region (2018-2023)
Table 9. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region (2024-2034)
Table 11. Rx Irritable Bowel Syndrome (IBS) Drugs Market Trends
Table 12. Rx Irritable Bowel Syndrome (IBS) Drugs Market Drivers
Table 13. Rx Irritable Bowel Syndrome (IBS) Drugs Market Challenges
Table 14. Rx Irritable Bowel Syndrome (IBS) Drugs Market Restraints
Table 15. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Players (2018-2023)
Table 17. Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs as of 2024)
Table 18. Ranking of Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Product Solution and Service
Table 22. Date of Enter into Rx Irritable Bowel Syndrome (IBS) Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2018-2023)
Table 26. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2024-2034)
Table 28. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application (2018-2023)
Table 30. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application (2024-2034)
Table 32. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 39. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 47. Ironwood Pharmaceuticals Company Detail
Table 48. Ironwood Pharmaceuticals Business Overview
Table 49. Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product
Table 50. Ironwood Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2018-2023) & (US$ Million)
Table 51. Ironwood Pharmaceuticals Recent Development
Table 52. Bausch Health Company Detail
Table 53. Bausch Health Business Overview
Table 54. Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Product
Table 55. Bausch Health Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2018-2023) & (US$ Million)
Table 56. Bausch Health Recent Development
Table 57. Takeda Company Detail
Table 58. Takeda Business Overview
Table 59. Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Product
Table 60. Takeda Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2018-2023) & (US$ Million)
Table 61. Takeda Recent Development
Table 62. Sebela Pharmaceuticals Company Detail
Table 63. Sebela Pharmaceuticals Business Overview
Table 64. Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product
Table 65. Sebela Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2018-2023) & (US$ Million)
Table 66. Sebela Pharmaceuticals Recent Development
Table 67. Allergan Company Detail
Table 68. Allergan Business Overview
Table 69. Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Product
Table 70. Allergan Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2018-2023) & (US$ Million)
Table 71. Allergan Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type: 2024 VS 2034
Figure 3. IBS-D Drugs Features
Figure 4. IBS-C Drugs Features
Figure 5. Others Features
Figure 6. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application: 2024 VS 2034
Figure 8. Women Case Studies
Figure 9. Men Case Studies
Figure 10. Rx Irritable Bowel Syndrome (IBS) Drugs Report Years Considered
Figure 11. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 12. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region: 2024 VS 2034
Figure 14. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Players in 2024
Figure 15. Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in 2024
Figure 17. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 18. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2018-2034)
Figure 19. United States Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. Canada Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2018-2034)
Figure 23. Germany Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. France Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. U.K. Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Italy Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Russia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Nordic Countries Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region (2018-2034)
Figure 31. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. South Korea Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Australia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2018-2034)
Figure 39. Mexico Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Brazil Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2018-2034)
Figure 43. Turkey Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Saudi Arabia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Ironwood Pharmaceuticals Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2018-2023)
Figure 46. Bausch Health Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2018-2023)
Figure 47. Takeda Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2018-2023)
Figure 48. Sebela Pharmaceuticals Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2018-2023)
Figure 49. Allergan Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2018-2023)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed